Literature DB >> 10796944

Endovascular stent-graft deployment: temporary vena caval occlusion with balloons to control aortic blood flow-experimental canine study and initial clinical experience.

T Ishiguchi1, N Nishikimi, A Usui, T Ishigaki.   

Abstract

Vena caval occlusion was evaluated in animal experiments. In five patients with thoracic aortic aneurysms, two balloon catheters were introduced via the femoral vein to the inferior vena cava and superior vena cava and inflated before stent-graft deployment. Aortic pressure and flow were immediately decreased, which minimized the downstream shift of the stent-grafts. Temporary vena caval occlusion is safe and effective for precise aortic stent-graft deployment.

Entities:  

Mesh:

Year:  2000        PMID: 10796944     DOI: 10.1148/radiology.215.2.r00ap19594

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  4 in total

1.  First-in-human experience with occlusion of the superior vena cava to reduce cardiac filling pressures in congestive heart failure.

Authors:  Navin K Kapur; Richard H Karas; Sarah Newman; Lena Jorde; Tina Chabrashvili; Shiva Annamalai; Michele Esposito; Carey D Kimmelstiel; Tim Lenihan; Daniel Burkhoff
Journal:  Catheter Cardiovasc Interv       Date:  2019-05-21       Impact factor: 2.692

2.  Endovascular repair of thoracic aortic injury: current thoughts and technical considerations.

Authors:  W Darrin Clouse
Journal:  Semin Intervent Radiol       Date:  2010-03       Impact factor: 1.513

3.  Stent strut penetration during thoracic endovascular aortic repair: report of a case.

Authors:  Masao Tadakoshi; Hiroyuki Ishibashi; Tsuneo Ishiguchi; Ikuo Sugimoto; Hirohide Iwata; Tetsuya Yamada; Noriyuki Hida; Takashi Ohta
Journal:  Surg Today       Date:  2011-11-18       Impact factor: 2.549

4.  Endovascular repair for a descending thoracic aortic aneurysm with a stent-graft covering the celiac artery: report of two cases.

Authors:  Hiroyuki Ishibashi; Tsuneo Ishiguchi; Takashi Ohta; Ikuo Sugimoto; Jun Kawanishi; Tetsuya Yamada; Noriyuki Hida; Seiji Kamei
Journal:  Surg Today       Date:  2009-05-27       Impact factor: 2.549

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.